Patent Challenge (ANDA)
12-01-2008 |
17:36 hs.
HIV Drug
11-17-2008 |
17:36 hs.
Israeli generic drug maker Teva Pharma submitted an abbreviated new drug application to the Food and Drug Administration requesting permission to make and market a generic version of Gilead Sciences’ HIV drug Truvada. The filing challenges two patents associated with Emtriva, a component of Truvada.
11-03-2008 |
08:41 hs.
10-29-2008 |
11:54 hs.
10-21-2008 |
19:36 hs.
10-17-2008 |
11:21 hs.
09-15-2008 |
12:39 hs.
08-25-2008 |
12:21 hs.
08-01-2008 |
12:10 hs.
07-31-2008 |
17:04 hs.
07-25-2008 |
10:15 hs.
07-16-2008 |
12:44 hs.
Shire is suing Nostrum Pharmaceuticals and Canadian firm Apotex for filing an ANDA (Abbreviated New Drug Application) to launch their 100 mg, 200 mg, and 300 mg versions of the anti-seizure drug Carbatrol, known generically as carbamazepine
06-11-2008 |
10:52 hs.
Japanese Takeda and former TAP Pharmaceuticals have filed a lawsuit against Barr Pharmaceuticals for infringement of their patent covering anti-acid Prevacid. Barr filed an application for its generic version of the popular medication.
06-05-2008 |
12:14 hs.
06-04-2008 |
12:53 hs.
06-03-2008 |
11:32 hs.
Biotech firm Gilead Sciences said that the U.S. Patent & Trademark Office (PTO) has confirmed the patentability of U.S. Patent No. 5,922,695, covering composition of matter for Viread (tenofovir disoproxil fumarate). Last May, the PTO upheld the first of the four challenged patents covering Gilead’s product. Two remaining patents are currently under examination
05-06-2008 |
13:23 hs.
Anglo-Swedish drugmaker AstraZeneca said that a key European patent covering the use of its asthma medication Symbicort as a treatment for chronic obstructive pulmonary disease (COPD), commonly known as “smoker’s cough” has been revoked by the European Patent Office
Patent and marketing exclusivity until September 2009
04-28-2008 |
13:12 hs.
Cephalon Inc. announced Watson Laboratories Inc. has filed an ANDA with the Food and Drug Administration to sell a generic version of its Fentora pain medication. Analysts believe the potential competition has some way still to go. Further details.
03-13-2008 |
19:51 hs.
Cholesterol Medication Tricor
03-03-2008 |
11:42 hs.
